Concepedia

Christopher Montemagno

CM

Statistics

Publications

15

Citations

405

H-Index

14

Active since

2016

Affiliations

Inserm(Current)

Centre National de la Recherche Scientifique

Institut de Recherche sur le Cancer et le Vieillissement de Nice

Centre Antoine Lacassagne

Scientific Centre of Monaco

Christopher Montemagno is an author at Inserm specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2016–2024

15

Publications

15

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

Christopher Montemagno, Anaïs Hagege, Delphine Borchiellini et al. · OncoImmunology · 2020 · 66 citations · Full text

, , +17

Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy

Damien Ambrosetti, Michael Coutts, Charlotte Paoli et al. · British Journal of Urology · 2021 · 58 citations

, , +17

LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers

Chloé Prunier, Véronique Josserand, Julien Vollaire et al. · Cancer Research · 2016 · 34 citations · Full text

, , +17

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma

Anaïs Hagege, Esma Saâda-Bouzid, Damien Ambrosetti et al. · Cell Reports Medicine · 2022 · 34 citations · Full text

, , +17

Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody

Maxime Nachit, Christopher Montemagno, Romain Clerc et al. · Nature Communications · 2023 · 24 citations · Full text

, , +17

1–5 of 15